Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Conrad Cairo Hotel

25 nov 2024 6:00 p.m. - 27 nov 2024 6:00 p.m.

1191 Nile Corniche, Cairo, 11221, Egypt

Middle East and North Africa Conference (MENA)

Parallel Session 5A: Modernising the Regulatory Framework to Enable Efficient Lifecycle Management

Session Chair(s)

Melly  Lin, MS

Melly Lin, MS

CMC Regulatory Policy Lead, Pharma Technical Regulatory, F. Hoffmann-La Roche Ltd, Switzerland

May  Shawky Mohamed

May Shawky Mohamed

Regional Manager Regulatory Affairs MEAR, Merck Group, United Arab Emirates

This session will focus on recent updates regarding the modernisation of the regulatory framework to facilitate the timely approval of PACs (Post-Approval Changes), including EDA’ s experience in reliance implementation to the variations’ system. In addition, two case studies from industry will be shared regarding how to enhance the use of reliance and PACMP (Post Approval Change Management Protocol) to accelerate PAC approval. Regulators and industry will discuss how to optimise the LCM framework by leveraging the lessons learnt from case studies, opportunities for harmonisation with international guideline and including PACMP in the local guideline, with the ultimate goal of enabling fast approval of PACs and securing supply of medicines to patients.

Speaker(s)

Melly  Lin, MS

Introduction and Setting the Scene: EFPIA MERN Survey on PAC management system in Middle East and North Africa

CMC Regulatory Policy Lead, Pharma Technical Regulatory, F. Hoffmann-La Roche Ltd, Switzerland

Hebatullah  Ibrahim

EDA’s Experience - Reliance for Post-Approval Changes

General Manager of biological Products General Administration, Egyptian Drug Authority (EDA), Egypt

Susanne  Ausborn, PHD

Case Study: Outcome of PAC Reliance Pilot with 48 countries

Global Head International Regulatory Policy, Roche, Switzerland

Ibrahim  Tlili, PHARMD, MPH, MSC

Case Study: Reliance and PACMPs to Accelerate a Major PAC Approval

Senior Scientist, International CMC EU/EEMEA, MSD, Switzerland

Sumaya  Husain

Panel Discussion with Q and A, with the additional participation of:

Clinical Trials Regulations Specialist, National Health Regulatory Authority (NHRA), Bahrain

Donia  Albastaki

Panel Discussion with Q and A, with the additional participation of:

Acting Director, Pharmaceutical and Herbal Medicine Registration & Control Admin, Ministry of Health, State of Kuwait, Kuwait

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.